Search Within

Joshua Drago

Formats
  1. Meeting Abstract (13)
  2. Journal Article (9)
  3. Editorial (4)
  4. Review (4)
  5. Conference Paper (1)
Groups
  1. Breast Medicine Service (31)
  2. CTCR Scholars (31)
  3. Department of Medicine (31)
  4. MSK Grad Students (31)
  5. Master of Science in Clinical and Translational Cancer Research (31)
  6. Solid Tumor Oncology Division (31)

More Groups

People
  1. Sarat Chandarlapaty (17)
  2. Shanu Modi (16)
  3. Pedram Razavi (13)
  4. Mark Robson (9)
  5. Komal Jhaveri (8)
  6. Fresia Pareja Zea (7)

More People

Years
  1. 2025 (5)
  2. 2024 (7)
  3. 2023 (4)
  4. 2022 (3)
  5. 2021 (5)
  6. 2020 (4)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Cancer Research (4)
  3. Clinical Cancer Research (3)
  4. Annals of Oncology (2)
  5. Cancer Discovery (2)
  6. Nature Reviews Clinical Oncology (2)

More Publications

Publishers
  1. American Association for Cancer Research (9)
  2. American Society of Clinical Oncology (9)
  3. Nature Publishing Group (4)
  4. Oxford University Press (3)
  5. Biomed Central Ltd (1)
  6. Cell Press (1)

More Publishers

Results (31)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Antibody drug conjugates in metastatic brain tumors: current landscape, therapeutic potential and challenges
    Review

    Robert, S. M.; Toth, A.; Lev, S.; Bowden, S. G.; Yu, Y.; Imber, B. S.; Boire, A.; Drago, J. Z.; Modi, S.; Moss, N. S.
    Journal of Neuro-Oncology (2025)

    Fulltext@MSK | Save
  • Effect of ERBB2 activating mutations on enhanced internalization and activity of trastuzumab deruxtecan in HER2-non-amplified metastatic breast cancer
    Meeting Abstract

    Mai, N.; Liu, B.; Safonov, A.; Shen, S.; Zelizer, S.; White, C.; Chen, Y.; Razavi, P.; Jhaveri, K. L.; Modi, S.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Detection of HER2-low lesions using HER2-targeted PET imaging in patients with metastatic breast cancer: A paired HER2 PET and tumor biopsy analysis
    Journal Article

    Yeh, R.; Pareja, F.; Shobeiri, P.; Ross, D.; Jayaprakasam, V. S.; Razmaria, A. A.; Drago, J. Z.; Mauguen, A.; Lyashchenko, S. K.; Zeglis, B. M.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Sequential antibody-drug conjugate therapy in patients with metastatic breast cancer treated with sacituzumab govitecan and trastuzumab deruxtecan
    Journal Article

    Mai, N.; Lieberman, M. M. K.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
    JCO Precision Oncology (2025)

    Fulltext@MSK | Save
  • Expanding the use of T-DXd in metastatic HR-positive breast cancer: Where are we now?
    Editorial

    Drago, J.; Modi, S.
    Nature Reviews Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Persistence and resistance of HER2 amplification after T-DM1 in a basket trial for patients with solid tumors
    Meeting Abstract

    Liu, D.; Arora, K.; Makker, V.; Buonocore, D.; Shen, R.; Yaeger, R.; Ginsberg, M. S.; Yeh, R.; Offin, M. D.; Solit, D.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • EGFR-directed antibodies promote HER2 ADC internalization and efficacy
    Journal Article

    Gupta, A.; Michelini, F.; Shao, H.; Yeh, C.; Drago, J. Z.; Liu, D.; Rosiek, E.; Romin, Y.; Ghafourian, N.; Thyparambil, S.; more...
    Cell Reports Medicine (2024)

    Fulltext@MSK | Save
  • Predictors of response to CDK4/6i retrial after prior CDK4/6i failure in ER+ metastatic breast cancer
    Journal Article

    Mai, N.; dos Anjos, C. H.; Razavi, P.; Safonov, A.; Patil, S.; Chen, Y.; Drago, J. Z.; Modi, S.; Bromberg, J. F.; Dang, C. T.; more...
    npj Breast Cancer (2024)

    Fulltext@MSK | Save
  • Phase 2 study of novel HER2-targeting, TLR7/8 immune-stimulating antibody conjugate (ISAC) BDC-1001 (trastuzumab imbotolimod) plus /- pertuzumab (P) in patients (pts) with HER2-positive metastatic breast cancer (MBC) previously treated with trastuzumab deruxtecan (T-DXd)
    Meeting Abstract

    Pegram, M. D.; Calfa, C.; Chen, C.; CorteĢs Salgado, A.; Heeke, A. L.; Kang, I.; Pistilli, B.; Pohlmann, P. R.; Rugo, H. S.; Saura, C.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real world outcomes of sequential ADC therapy in metastatic breast cancer: Patients treated with sacituzumab govitecan and trastuzumab deruxtecan
    Meeting Abstract

    Mai, N.; Klar, M.; Ferraro, E.; Bromberg, M.; Chen, Y.; Razavi, P.; Modi, S.; Chandarlapaty, S.; Walsh, E. M.; Drago, J. Z.
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save